This M1 activation is characterized by an increase in p38/p65 signal transduction and proinflammatory cytokines, which promotes the infiltration and activation of CD4+ and CD8+ T cells in the tumor microenvironment [109]. The gene discussed is CD4; the disease is neoplasm.